OliX Pharmaceuticals, Inc

₩74,800As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:226950Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR 14.14%
Div yield —
ROE (10.76%)
Biotechnology
Beta (5Y) 0.43
PE TTM —
TSR TTM (36.88%)
Mkt cap ₩1.702T
ROIC (16.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩80,670
7.85%
(89.46%)
Hold 1|4|6|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,576
1,683
1,609
1,660
4.85%
17.30%
9.35%
7.67%
Revenue₩B
99.13
100.3
100.4
99.15
12.35%
9.20%
8.28%
3.36%
Peers (US$1.255B)
Cap (US$)
PE
1.488B
—
1.274B
—
Capital
TTM
5Y
10Y
Leveragex
0.205
1.758
1.407
EBIT/Intx
0.836
0.125
0.117
Own earn%
135.02
80.69
92.91
Sh yield%
37.25
42.89
42.13
Owners
Insiders/Inst%
2.82
27.48
Short interest%
2.64
SBC / revenue%
0.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
12–20
$1 testx
0.0
Incr. ROIC%
1